Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
A teratoma is a congenital (present prior to birth) tumor formed by different types of tissue.
Teratomas in newborns are generally benign and don't spread. They can, however, be malignant, depending on the maturity and other types of cells that may be involved.
Benign teratomas tend to grow aggressively, although they do not spread.
Malignant teratomas tend to grow aggressively and spread to other parts of the body.
Individualized care, new treatments
Through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, a 50-year partnership between Dana-Farber Cancer Institute and Boston Children's Hospital, your child will receive individualized care to treat every aspect of his condition from an expert team of specialists.
Your child will also benefit from a team of researchers striving to understand the scientific causes of teratomas, which results in continual introduction of new treatment options.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”